These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37016314)

  • 1. A prospective, double-blinded cohort study using quantitative fetal fibronectin testing in symptomatic women for the prediction of spontaneous preterm delivery.
    Ng VWY; Seto MTY; Lewis H; Cheung KW
    BMC Pregnancy Childbirth; 2023 Apr; 23(1):225. PubMed ID: 37016314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 4. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis.
    Deshpande SN; van Asselt AD; Tomini F; Armstrong N; Allen A; Noake C; Khan K; Severens JL; Kleijnen J; Westwood ME
    Health Technol Assess; 2013 Sep; 17(40):1-138. PubMed ID: 24060096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of fetal fibronectin for the prediction of preterm birth in symptomatic twin pregnancies: a pilot study.
    Fuchs F; Lefevre C; Senat MV; Fernandez H
    Sci Rep; 2018 Feb; 8(1):2160. PubMed ID: 29391455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic model, including quantitative fetal fibronectin, to predict preterm labour: the QUIDS meta-analysis and prospective cohort study.
    Stock SJ; Horne M; Bruijn M; White H; Heggie R; Wotherspoon L; Boyd K; Aucott L; Morris RK; Dorling J; Jackson L; Chandiramani M; David A; Khalil A; Shennan A; Baaren GV; Hodgetts-Morton V; Lavender T; Schuit E; Harper-Clarke S; Mol B; Riley RD; Norman J; Norrie J
    Health Technol Assess; 2021 Sep; 25(52):1-168. PubMed ID: 34498576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.
    Bruijn M; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers H; Spaanderman M; Bloemenkamp K; Haak MC; Bolte AC; Vandenbussche F; Woiski MD; Bax CJ; Cornette J; Duvekot JJ; Nij Bijvanck B; van Eyck J; Franssen M; Sollie KM; van der Post J; Bossuyt P; Opmeer BC; Kok M; Mol B; van Baaren GJ
    BJOG; 2016 Nov; 123(12):1965-1971. PubMed ID: 26667313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of blood staining on cervicovaginal quantitative fetal fibronectin concentration and prediction of spontaneous preterm birth.
    Hezelgrave NL; Kuhrt K; Cottam K; Seed PT; Tribe RM; Shennan AH
    Eur J Obstet Gynecol Reprod Biol; 2017 Jan; 208():103-108. PubMed ID: 27918947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative fetal fibronectin predicts preterm birth in women with bulging fetal membranes.
    Fiorini F; Isted A; Hezelgrave NL; Shennan AH
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():127-31. PubMed ID: 27280542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fetal fibronectin test is superior to cervical length measurement in predicting preterm birth in twin pregnancies: a retrospective observational study.
    Holzer I; Koch-Trappel M; Leitich H; Meyer EL; Farr A; Helmer H
    Eur J Obstet Gynecol Reprod Biol; 2020 Apr; 247():22-25. PubMed ID: 32058186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of quantitative fFn test in predicting the risk of preterm birth.
    Centra M; Coata G; Picchiassi E; Alfonsi L; Meniconi S; Bini V; Di Tommaso MR; Cozzolino M; Facchinetti F; Ferrari F; Gervasi MT; Rusconi S; Todros T; Frisina V; Rizzo N; Bisulli M; Di Renzo GC
    J Perinat Med; 2017 Jan; 45(1):91-98. PubMed ID: 27049613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fetal fibronectin for threatened preterm labour in reducing inappropriate interventions.
    Mahomed K; Anwar S; Geer JE; Ballard E; Okano S
    Aust N Z J Obstet Gynaecol; 2019 Aug; 59(4):523-527. PubMed ID: 30393916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of cervical electrical impedance spectroscopy to predict spontaneous preterm delivery in asymptomatic women: the ECCLIPPx prospective cohort study.
    Anumba DOC; Stern V; Healey JT; Dixon S; Brown BH
    Ultrasound Obstet Gynecol; 2021 Aug; 58(2):293-302. PubMed ID: 32798253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The efficacy of quantitative fetal fibronectin in predicting spontaneous preterm birth in symptomatic women: A retrospective cohort study.
    Nguyen AD; Liu CZ; Lehner C; Amoako AA; Sekar R
    Aust N Z J Obstet Gynaecol; 2019 Oct; 59(5):656-661. PubMed ID: 30724331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.